This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit         May 09, 2014




 


HEADLINES

AAPS Career News
Pharmaceutical Career News


AAPS CAREER NEWS


Save the Date! The first AAPS Virtual Career Fair is June 18th!!
Meet employers who are looking for candidates just like you at the AAPS one-of-a-kind Virtual Career Fair!

Be there on June 18th at the free AAPS Virtual Career Fair and meet employers seeking high caliber pharmaceutical scientists and biotechnology professionals that AAPS members represent.

The AAPS Virtual Career Fair is unique. Taking place online, it's the perfect setting for professionals looking to discover potential career opportunities. And you don't even need to be in active job-search mode to benefit from seeing the positions employers have open. The AAPS Virtual Career Fair is a great way for you to scout out openings more confidentially than you could in a traditional on-site career fair.

For more information please go to our Virtual Career Fair webpage. If you have any questions, please contact Kevin Folk, Career Services Manager, at +1.703.248.4721 or email FolkK@aaps.org.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Return to Headlines


Attending the AAPS National Biotechnology Conference? Sign up today for a free on-site résumé review!
New this year we are offering a résumé review for candidates who would like advice on sharpening their résumé. We have limited space, and preconference sign-up is required.

To schedule your day and time, please email Kevin Folk at: FolkK@aaps.org. Sign up today!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Return to Headlines


Are Your Résumé and Interviewing Skills up to Snuff?
We all want to look good and get noticed when we apply and interview for a job. What do hiring managers look for when they review candidates?

Two members of the American Association of Pharmaceutical Scientists (AAPS) recently shared their experience as hiring managers at the AAPS Annual Meeting and Exposition in San Antonio. Andy Vick, Ph.D., is a senior director of analytical services at WIL Research, and Russell Weiner, Ph.D., is an executive director at Merck Research Laboratories.

When reviewing résumés, hiring managers frequently spend less than five minutes. In that quick review, Vick says, he wants to confirm that the candidate satisfies the minimum qualifications of the job (both in education and technical requirements). In particular, he looks for:
  • Specifics (dates, job description, etc.)
  • Path of professional development, including positions, courses, volunteerism
  • Signs of achievement / results
  • Job stability and career direction
  • High-quality résumé or curriculum vitae (CV) construction and appearance (organized presentation, easy to read, with sound grammar)
These criteria suggest that preparing for the job search begins long before sending out the résumé. Standing out in that initial review requires building credentials and making yourself a desirable job candidate.

To read more on preparing for your job search, please refer to our new Career Success section of the AAPS Career Center.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Return to Headlines


PHARMACEUTICAL CAREER NEWS


Q&A: The Great Pharmaceutical Garage Sale of 2014
The Wall Street Journal
Over the past month, several large drug makers have reportedly begun considering the sale of some of their older medicines. Among them are Merck, Sanofi, GlaxoSmithKline and Abbott Laboratories. And Pfizer continues to look at breaking up its pharmaceutical business into separate entities, including a unit for older drugs, or ‘established products,’ that might eventually be spun off. Which drugs may be sold is not clear, but the Zocor cholesterol pill or Propecia baldness treatment have been named as possible candidates. The idea is to generate cash by unloading drugs offering diminishing returns and use the money to develop products that would, presumably, generate higher margins.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


Why 9 Is The Magic Number For Boosting Your Career
Forbes
About a year ago, the folks at LinkedIn approached me with a question: How much daily time should career-minded professionals devote to managing their brand? How many “clock hours” does it really take to achieve those professional goals? It was a great question. Before coming to me, they had done some research of their own, which revealed that most people think they need to devote 30 minutes or more each day. Who has that kind of free time to focus on personal branding? Unfortunately, because we believe we need to devote such a significant chunk of time, we end up devoting none.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


Pharmaceutical Industry: Finding A Cure
The Guardian
The post-crash experience, where neither global economic meltdown nor mass public outrage has yet to produce an equivalent revolution in business or industrial policy, is a stark reminder of how fear can inhibit reform. Governments learned too well the lessons of the postwar period, when the attempt to dictate policy was one factor in the decline of British industry. But they are also over-impressed by the successful mergers that came later – the Nissans and Tatas that have invested in and transformed Britain's automotive industry. The attempted takeover by Pfizer of AstraZeneca is an illustration of how dangerous this might be.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


When Betting on a Losing Company Is a Great Career Move
Bloomberg Businessweek
In early 2003, McDonald’s looked, from the outside, like the kind of company an ambitious executive should avoid. The fast-food giant had just booked its first quarterly loss since the 1960s. Comparable store sales had declined for two years. Customer satisfaction was low. McDonald’s stock was tanking as the markets rallied. If things were so bad, why did Eric Leininger take a job with McDonald’s rather than pursue one of the many opportunities regularly presented to him as a senior vice president at Kraft Foods? Because the opportunity was exactly right.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


Indian Pharma Sector's Rise a Challenge to Global Industry
SME Times
The Indian pharmaceutical industry is emerging as a global leader, raising concerns for its global counterparts in other parts of the world, including the US, said Pharmaceuticals Export Promotion Council of India (Pharmaexcil) Chairman Ashutosh Gupta in New Delhi. Replying to a question raised by media on the ongoing differences between India and the US over the Intellectual Property Rights issue, Gupta said that the Indian pharmaceutical sector, driven by large labour force, skills and education, is emerging as a potent competitor to the developed countries, and this may be the reason, he hinted, why some countries, including the US feeling an increased heat.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


No Longer King Of The North, Pfizer Looks To Recapture Crown
Forbes
Business is war and nothing is more illustrative of that point than a healthy cycle of M&A activity. Amid a wave of healthcare transactions, Pfizer, one of the world’s largest pharmaceutical companies, announced a $100 billion bid for the British pharmaceutical company AstraZeneca. What if this were the least bad choice for Pfizer in an increasingly challenging business environment? Pfizer, like other large pharmaceutical companies, is struggling.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


Big Pharma Is Innovating By Selling Old Drugs — And Making A Lot Of Money In The Process
Reuters via Business Insider
Leading global pharmaceutical companies have started to view their vast portfolios of older, established prescription drugs as vehicles for raising large sums of cash to fuel development of new medicines with far higher profit margins. France's Sanofi and U.S. drugmakers Merck & Co and Abbott Laboratories are exploring selling off their mature drugs that have lost patent protection, Reuters reported this week, citing people familiar with the plans. Officials at the three companies declined to comment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


NBA's Silver Shows New Leaders How To Sail Through Rough Waters
By Ryan Clark
"Anyone can hold the helm when the sea is calm," states Publilius Syrus, a Latin writer in the first century B.C. Although penned more than 2,000 years ago, the words could have very well been written in response to today's headlines. NBA Commissioner Adam Silver was just forced into a public show of authority only three months after taking the reins from David Stern on Feb. 1. After a short investigation, Silver fined and ultimately banned controversial Los Angeles Clippers owner Donald Sterling after the latter was recorded making racist comments about African-Americans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


Cumberland, Gloria Partner to Accelerate Development of CET's New Product Candidates
Pharmaceutical Business Review
U.S.-based Cumberland Pharmaceuticals and China's Gloria Pharmaceuticals have entered into a joint R&D initiative to accelerate development of Cumberland Emerging Technologies' (CET) new product candidates. Under the deal, each company has made a $1 million investment in CET, which is majority owned by Cumberland and partners with academic research centers to develop promising biopharmaceutical technologies. The investment will be used to accelerate development of CET's pipeline of new product candidates emerging from Vanderbilt University and other regional research centers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines


4 Easy Ways To Have A Better Day At Work
By Catherine Iste
As HR professionals, my peers and I are constantly bombarded by negative things at work. A typical day in HR can include employees complaining about each other, their pay or problems with their benefits. Few people go to HR because they are happy about how things are going at work. Worse, if you are sent to HR, it is like being sent to the principal's office in high school.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Return to Headlines
 



AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit

Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169  
Contribute news


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

April 11, 2014
March 14, 2014
Feb. 14, 2014
Jan. 10, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063